Cargando…

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery

Obesity and type 2 diabetes (T2D) are growing burdens for individuals and the health-care system. Bariatric surgery is an efficient, but drastic treatment to reduce body weight, normalize glucose values, and reduce low-grade inflammation. The gut microbiome, which is in part controlled by intestinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheithauer, Torsten P.M., Davids, Mark, Winkelmeijer, Maaike, Verdoes, Xanthe, Aydin, Ömrüm, de Brauw, Maurits, van de Laar, Arnold, Meijnikman, Abraham S., Gerdes, Victor E.A., van Raalte, Daniël, Herrema, Hilde, Nieuwdorp, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824225/ https://www.ncbi.nlm.nih.gov/pubmed/35130127 http://dx.doi.org/10.1080/19490976.2022.2031696

Ejemplares similares

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
por: Hoozemans, Jacqueline, et al.
Publicado: (2021)

Attachment style and post-bariatric surgery health behaviours: the mediating role of self-esteem and health self-efficacy
por: Pyykkö, Johanna Eveliina, et al.
Publicado: (2023)

Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery
por: Lappa, Dimitra, et al.
Publicado: (2023)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration
por: Mikkelsen, Randi Bonke, et al.
Publicado: (2022)

Psychological functioning and well‐being before and after bariatric surgery; what is the benefit of being self‐compassionate?
por: Pyykkö, Johanna Eveliina, et al.
Publicado: (2021)

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
por: Aydin, Ömrüm, et al.
Publicado: (2018)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery
por: Guman, M.S.S., et al.
Publicado: (2022)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Pancreatitis following bariatric surgery
por: Baran, Kiran Chandni, et al.
Publicado: (2019)

A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
por: Meijnikman, Abraham S., et al.
Publicado: (2022)

The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial)
por: van Rijswijk, A., et al.
Publicado: (2022)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016)

Pancreatic (18)F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
por: Bakker, Guido J., et al.
Publicado: (2019)

Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers
por: Guman, Maimoena S. S., et al.
Publicado: (2023)

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes
por: Habibe, Jayron J., et al.
Publicado: (2022)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study
por: Van Olden, C. C., et al.
Publicado: (2020)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)
por: Haal, Sylke, et al.
Publicado: (2020)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric Bypass
por: Wijdeveld, Madelief, et al.
Publicado: (2023)

Weight Loss Results and Compliance with Follow-up after Bariatric Surgery
por: Reiber, Beata M. M., et al.
Publicado: (2021)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
por: Boerlage, Thomas C. C., et al.
Publicado: (2017)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery
por: Louca, Panayiotis, et al.
Publicado: (2023)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
por: de Groot, Pieter F., et al.
Publicado: (2017)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux‐en‐Y gastric bypass surgery
por: Geubbels, N., et al.
Publicado: (2019)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Bridging the gap between gastric pouch and jejunum: a bariatric nightmare
por: Geubbels, Noëlle, et al.
Publicado: (2015)

Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery
por: Haal, Sylke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f1prdq1d7mqjq2abqpgf66s8v2